NGL FINE-CHEM LTD.

NGL Fine-Chem Limited has submitted its Annual Report for the Financial Year 2025-26, along with the notice for its 45th Annual General Meeting (AGM) scheduled for August 25, 2026. The report highlights a significant recovery in FY26, with revenue from operations increasing by 36% to ₹500.95 crores. EBITDA more than doubled to ₹72.69 crores, and profit after tax grew by 128% to ₹48.13 crores. This growth was driven by increased volumes, improved capacity utilization, and disciplined cost management. The company is focusing on expanding into regulated markets and has advanced its CEP, ASMF, and VMF pipelines. Phase I of the greenfield expansion at Tarapur is operational, with Phase II expected to support commercial production from the second half of FY27.

NGL Fine-Chem Limited has submitted its Business Responsibility and Sustainability Reporting (BRSR) for the financial year 2025-26, in compliance with SEBI (LODR) Regulations, 2015. The report, which forms part of the Integrated Annual Report, details the company's commitment to integrating Environmental, Social, and Governance (ESG) principles into its core strategy. NGL Fine-Chem emphasizes sustainable operations for enduring enterprise value, focusing on environmental stewardship, social capital, and robust governance. The company manufactures pharmaceuticals and intermediates for veterinary and human health, with 100% of its turnover derived from this activity. Operations are primarily domestic, with a significant international market presence across 54 countries.

NGL Fine-Chem Limited has submitted the Notice for its 45th Annual General Meeting (AGM) and the Annual Report for the Financial Year 2025-26. The AGM is scheduled for August 25, 2026, to be held via Video Conferencing. The company reported a strong financial performance for FY26, with revenue increasing by 36% to ₹500.95 crores, EBITDA more than doubling to ₹72.69 crores, and profit after tax growing by 128% to ₹48.13 crores. This recovery was driven by volume growth, improved capacity utilization, and cost management. The company is focused on its 'Building for the Next Phase of Growth' strategy, with ongoing greenfield expansion at Tarapur and advancements in regulated markets, including CEP, ASMF, and VMF pipelines. The report highlights investments in manufacturing, R&D, and global presence, positioning NGL Fine-Chem for sustained long-term value creation.

NGL Fine Chem Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is effective from Wednesday, July 1, 2026, and will remain in effect until 48 hours after the declaration of the company's unaudited financial results for the quarter ended June 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct to prevent insider trading. The date of the board meeting to consider these financial results will be communicated separately.

NGL Fine Chem Ltd's board approved the audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹1.75 per share. The 45th Annual General Meeting (AGM) will be held on August 25, 2026, via video conferencing. The record date for the AGM and dividend payment is August 18, 2026, with the register of members and share transfer books closed from August 19-25, 2026.

NGL Fine Chem Ltd's board approved the audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹1.75 per share. The 45th Annual General Meeting (AGM) will be held on August 25, 2026, via video conferencing. The record date for the AGM and dividend payment is August 18, 2026. The register of members and share transfer books will be closed from August 19 to August 25, 2026. Appointments of internal and cost auditors were also approved, along with the reappointment of Mr. Rajesh Lawande and Mrs. Sarala Menon as Whole-Time and Independent Directors, respectively.

NGL Fine Chem Ltd's board approved audited financial results (standalone & consolidated) for the quarter and year ended March 31, 2026. They recommended a final dividend of ₹1.75 per share. The 45th AGM will be held on August 25, 2026, via video conferencing. They also approved the reappointment of Mr. Rajesh Lawande as Whole-Time Director and Mrs. Sarala Menon as an Independent Director, subject to shareholder approval.

NGL Fine Chem Ltd's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. They recommended a final dividend of ₹1.75 per share. The 45th AGM will be held on August 25, 2026, via video conferencing, with a record date of August 18, 2026. The board also approved the reappointment of Mr. Rajesh Lawande as Whole-Time Director and Mrs. Sarala Menon as an Independent Director, subject to shareholder approval.

NGL Fine Chem Ltd's board meeting on May 21, 2026, approved the audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹1.75 per share. The 45th AGM is scheduled for August 25, 2026, via video conferencing. The board also approved the reappointment of Mr. Rajesh Lawande as Whole-Time Director and Mrs. Sarala Menon as an Independent Director, subject to shareholder approval. Additionally, M/s. KD Practice Consulting Pvt. Ltd. was appointed as Internal Auditors and M/s. Sanghavi Randeria & Associates as Cost Auditor for FY 2026-27.

NGL Fine Chem Ltd's board approved the audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹1.75 per share. The 45th AGM is scheduled for August 25, 2026, via video conferencing, with a record date of August 18, 2026. The board also approved the reappointment of Mr. Rajesh Lawande as Whole-Time Director and Mrs. Sarala Menon as an Independent Director, subject to shareholder approval. Additionally, M/s. KD Practice Consulting Pvt. Ltd. was appointed as Internal Auditors and M/s. Sanghavi Randeria & Associates as Cost Auditor for FY 2026-27.